首药控股

688197 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

5.4B ($791.0M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

3.9M

Net Income

-212.0M

Gross Margin

N/A

Op. Margin

-53.8%

Net Margin

-53.8%

ROE

-26.2%

ROA

-23.0%

D/E

0.14

Dividend Yield

N/A

EPS

-1.43

Current Ratio

7.03

Price History

Company Info

Industry	C27医药制造业
Market Segment	STAR Market
Currency	CNY
Fiscal Year	2024

Business Overview

Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China. The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 首药控股

Ticker	688197
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业